Sheba Pediatric Personalized CAR-T Immunotherapy Program for Blood Cancers at JCI accredited and Top-10 Hospitals 2026 by Newsweek Hospital
このパッケージに含まれるもの
医療処置
- CAR-T細胞療法
- 栄養士による1日3食
- 24時間看護サービス
- CT検査
- 心電図(ECG)
- 血液検査
- 胸部X線
- HIV抗体検査
- B型肝炎コア抗体検査
- 抗HCV抗体検査
- 心エコー図検査
- 全血球計算(CBC)
- 生化学血液検査
- 腫瘍専門医との診察
- 血液専門医へのコンサルテーション
- 小児血液専門医との相談
- 小児科医との相談
- 腫瘍血液専門医との診察
- 頭部MRI
- 生検
- 腫瘍マーカーおよび蛋白分画を含む全血球算定
期間
- 21 日 病院で
宿泊
入院
交通
空港-ホテル間送迎
追加情報
Sheba Pediatric Personalized CAR-T Immunotherapy Program for Blood Cancers
At Sheba Medical Center, children and young patients receive some of the most advanced and compassionate cancer care available today. Sheba is a global leader in pediatric CAR-T cell therapy, offering highly personalized treatment for complex and resistant blood cancers, including:
• Acute lymphoblastic leukemia (ALL) and Acute Myeloid Leukemia (AML)
• Non-Hodgkin lymphomas (DLBCL, FL, MCL)
• Burkitt lymphoma
• CLL / Richter’s transformation
• Primary CNS lymphoma
• Multiple myeloma
A Gentle, Fully Integrated CAR-T Journey
Every step of the CAR-T process is performed on-site at Sheba, ensuring speed, safety, and the highest quality of care, especially important for children.
The treatment includes three carefully coordinated stages:
• Apheresis – collecting the child’s own immune (T) cells
• Cell Engineering – reprogramming the cells at Sheba’s Advanced Biotherapy Center
• Infusion – returning the cells to fight the cancer
Because everything is done within the hospital, treatment can begin quickly and is typically completed within ~10 days. CAR-T works as a “living therapy,” continuing to act in the body and offering the potential for long-term remission.
All patients are treated under the guidance of leading experts, including Prof. Amos Toren, with dedicated pediatric CAR-T teams ensuring continuous monitoring and care.
Designed Especially for Children and Families
Sheba understands that treating a child means caring for the entire family. The pediatric program offers:
• Specialized pediatric CAR-T units with 24/7 expert monitoring
• A multidisciplinary team of hemato-oncologists, immunologists, and pediatric specialists
• A supportive, child-friendly environment focused on comfort and safety
• Full international patient support, including travel and care coordination
Clinical Excellence You Can Trust
Sheba is one of the world’s leading centers in pediatric CAR-T, with strong clinical outcomes:
• ~90% remission in pediatric patients
• ~80% in young adults (up to 23 years)
• ~70% in adults
Importantly, Sheba offers flexibility in age criteria, ensuring that children and young patients can access advanced therapies when needed.
Comprehensive Care from Start to Finish
Each child receives a complete evaluation before treatment, including:
advanced imaging, bone marrow testing, genetic and molecular analysis, and full cardiac and pulmonary assessment.
Care is provided in English, Russian, and Arabic, helping families feel supported and informed throughout the entire journey.
Why Families Choose Sheba
By combining advanced science, speed, and deeply personalized care, Sheba provides one of the most trusted pediatric CAR-T programs in the world focused not only on treating disease, but on giving children the best possible chance to return to a healthy, active life.
24時間年中無休Bookimedサポート
- 専任医療コーディネーター
- 医療旅行手配 — 特別パートナー価格での航空券・ホテル予約
- 医療旅行中の患者擁護
プログラム料金
このパッケージに含まれないもの
医師
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
調子はいかがですか?
クリニックについて
シェバ医療センターはイスラエルおよび世界有数の病院の一つです。 ニューズウィーク・インターナショナル誌は、Sheba Hospitalを2020年の世界トップ10病院にランク付けしました。同病院は1,990の専門分野をカバーしており、毎年世界中から1,500,000人を超える患者がシェバ病院を受診しています。
支払い・特典
当社サービスへのお支払いはありません
クリニックで直接またはその公式銀行口座にお支払いいただきます。
一部のクリニックでは保証金が必要な場合があります。
分割払いオプションでお支払いを分散してください。
Bookimedにお友達を紹介して報酬を獲得してください。